Genomewide interaction and enrichment analysis on antidepressant response
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Background: Genomewide association studies (GWASs) on antidepressant efficacy have yielded modest results. A possible reason is that response is influenced by other factors, which possibly interact with genetic variation. We used a GWAS model to predict antidepressant response, by including predictors previously known to affect response, such as quality of life (QoL). We also evaluated the association between genes, previously implicated in gene–environment (G × E) interactions, and response using an enrichment analysis. Method: We examined a sample of 1426 depressed patients from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: 774 responders, 652 non-responders and 418 865 single nucleotide polymorphisms (SNPs) were analysed. First, in a GWAS model, we investigated whether genetic variations interact with patients' levels of QoL to predict response, after controlling for demographic characteristics, severity and population stratification. Second, we conducted an enrichment analysis exploring whether candidate genes that have emerged from prior G × E interaction studies on depression are associated with treatment response. Results: The GWAS model, with QoL as a moderator, yielded one SNP (rs520210) associated with response in the NEDD4L gene (p = 3.64 × 10−8). In the Caucasian sample only, we observed a drop in significance for this SNP. The enrichment analysis showed that SNPs within serotonergic genes contained more significant markers that predicted response, compared with a random set of genes in the genome. Conclusions: Our findings point to possible target genes, which are proposed for further independent replication. Our enrichment analysis provides further support, in a genomewide context, of the role of serotonergic genes in influencing antidepressant response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · cited 2×
“This analysis was conducted in order to control for a possible lack in reliability due to the inclusion of the interaction term in the first model (Purcell et al. 2007).”
MethodPrincipal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248 · cited 2×
“(2010) and as previously suggested (Price et al. 2006).”
MethodTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 3×
“For example, in a large, multicentre trial, the Sequenced Treatment Alternatives to Relieve Depression (STAR*D), approximately one in three patients with MDD achieved remission after being treated with the selective serotonin reuptake inhibitor (SSRI) citalopram (Trivedi et al. 2006a).”
Background(1993) · PubMed · Cited by 1,900
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Galat, A., Uehling, D. E., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,396 · cited 1×
“FKBP12 is the prototype of the FKBP family and binds immunosuppressive drugs, such as FK506 and rapamycin (Harding et al. 1989).”
BackgroundData quality control in genetic case-control association studies
Anderson, C. A., Pettersson, F. H., Clarke, G. M., Cardon, L. R., Morris, A. P., & Zondervan, K. T. (2010) · Nature Protocols · doi:10.1038/nprot.2010.116 · Cited by 1,318 · cited 1×
“Another 88 participants were removed because they had more than 5% of their genotypes missing; 30 participants were shown to be cryptically related to others in the sample [assessed using an identity by descent (IBD) >0.1875 in PLINK; Anderson et al. 2010].”
BackgroundInfluentialBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977 · cited 2×
“From the FKBP group, FKBP5 has been previously associated with the recurrence of depressive episodes and antidepressant response in an independent study (Binder et al. 2004), and in the STAR*D trial using a candidate gene approach (Lekman et al. 2008).”
MethodResultPhipson, B., & Smyth, G. K. (2010) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1585 · Cited by 712 · cited 1×
“The permuted pwas then extracted from the 105 Fisher tests, as suggested previously (Phipson & Smyth, 2010).”
MethodA genome-wide linkage and association scan reveals novel loci for autism
The Gene Discovery Project of Johns Hopkins & the Autism Consortium, Weiss, L. A., & Arking, D. E. (2009) · Nature · doi:10.1038/nature08490 · Cited by 619 · cited 2×
“Furthermore, other genes that were consistently observed in the Caucasian, as well as in the whole, sample were an intergenic region near SEMA5A, which has been previously associated with autism (Weiss et al. 2009), intergenic regions near SLC37A1 (which is a glycerol-3-phosphate transporter), and the LRCH1 gene; the…”
BackgroundNuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior
Koo, J. W., Russo, S. J., Ferguson, D., Nestler, E. J., & Duman, R. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910658107 · Cited by 607
Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0713 · Cited by 521 · cited 1×
“Whereas it is estimated that about 50% of patients with uncomplicated MDD will respond to any single antidepressant (Papakostas & Fava, 2008, 2009), other reports show lower response rates (Souery et al. 2007).”
BackgroundSelf-citationFava, M., Rush, A. J., Trivedi, M. H., Nierenberg, A. A., Thase, M. E., Sackeim, H. A., Quitkin, F. M., Wisniewski, S., Lavori, P. W., Rosenbaum, J. F., et al. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00107-7 · Cited by 519 · cited 1×
“The STAR*D trial has been previously described in detail elsewhere (Fava et al. 2003; Rush et al. 2003).”
MethodMcMahon, F. J., Buervenich, S., Charney, D., Lipsky, R., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Papanicolaou, G. J., Laje, G., Fava, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503820 · Cited by 474 · cited 1×
“The HTR2A gene was previously studied in the STAR*D sample, using a candidate gene approach, by McMahon et al. (2006), who examined 68 candidate genes and found significant associations with only two intronic variants in the HTR2A and treatment response.”
MethodReview and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Kato, M., & Serretti, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.116 · Cited by 450 · cited 1×
“On the other hand, there is a substantial research showing that candidate polymorphisms of target proteins may be involved in antidepressant drug action (Serretti et al. 2005; Kato & Serretti, 2010; Porcelli et al. 2011).”
BackgroundSelf-citationUher, R., & McGuffin, P. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.123 · Cited by 424 · cited 6×
“Whereas it is estimated that about 50% of patients with uncomplicated MDD will respond to any single antidepressant (Papakostas & Fava, 2008, 2009), other reports show lower response rates (Souery et al. 2007).”
BackgroundInfluentialPapakostas, G. I., & Fava, M. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.08.009 · Cited by 382 · cited 1×
“Whereas it is estimated that about 50% of patients with uncomplicated MDD will respond to any single antidepressant (Papakostas & Fava, 2008, 2009), other reports show lower response rates (Souery et al. 2007).”
BackgroundGenome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
Uher, R., Perroud, N., Ng, M. Y. M., Hauser, J., Henigsberg, N., Maier, W., Mors, O., Placentino, A., Rietschel, M., Souery, D., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09070932 · Cited by 350 · cited 2×
“To date, genomewide association studies (GWASs) on treatment response of antidepressants (Ising et al. 2009; Garriock et al. 2010; Uher et al. 2010) provide modest results, which do not reach genomewide significance and are hard to replicate, thereby making any translation into potential clinical…”
BackgroundLicht, C. M. M., de Geus, E. J. C., Seldenrijk, A., van Hout, H. P. J., Zitman, F. G., van Dyck, R., & Penninx, B. W. J. H. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.126698 · Cited by 319 · cited 1×
“interesting, since it has been recently shown that depressed patients under serotonergic antidepressant treatment have an increased risk of hypertension (Licht et al. 2009).”
BackgroundIsing, M., Lucae, S., Binder, E. B., Bettecken, T., Uhr, M., Ripke, S., Kohli, M. A., Hennings, J. M., Horstmann, S., Kloiber, S., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.95 · Cited by 306 · cited 1×
“To date, genomewide association studies (GWASs) on treatment response of antidepressants (Ising et al. 2009; Garriock et al. 2010; Uher et al. 2010) provide modest results, which do not reach genomewide significance and are hard to replicate, thereby making any translation into potential clinical…”
BackgroundA Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Garriock, H. A., Kraft, J. B., Shyn, S. I., Peters, E. J., Yokoyama, J. S., Jenkins, G. D., Reinalda, M. S., Slager, S. L., McGrath, P. J., & Hamilton, S. P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.029 · Cited by 288 · cited 9×
“This sample and genotyping techniques have been described in detail by Garriock et al. (2010).”
BackgroundMethodResultInfluentialLekman, M., Laje, G., Charney, D., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Lipsky, R., Wisniewski, S. R., Manji, H., McMahon, F. J., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.026 · Cited by 284 · cited 2×
“From the FKBP group, FKBP5 has been previously associated with the recurrence of depressive episodes and antidepressant response in an independent study (Binder et al. 2004), and in the STAR*D trial using a candidate gene approach (Lekman et al. 2008).”
MethodZimmermann, P., Brückl, T., Nocon, A., Pfister, H., Binder, E. B., Uhr, M., Lieb, R., Moffitt, T. E., Caspi, A., Holsboer, F., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111577 · Cited by 262 · cited 1×
“Furthermore, the FKBP5 modulated effects of childhood trauma in predicting major depression (Appel et al. 2011; Zimmermann et al. 2011).”
BackgroundCNS Gene Encoding Astrotactin, Which Supports Neuronal Migration Along Glial Fibers
Zheng, C., Heintz, N., & Hatten, M. E. (1996) · Science · doi:10.1126/science.272.5260.417 · Cited by 251 · cited 2×
“The neuronal protein astrotactin (ASTN1) is a well-known receptor for glial-guided neuronal migration (Fishell & Hatten, 1991; Zheng et al. 1996), a fundamental process in the development of the laminar structure of cortical regions of the brain (Wilson et al. 2010).”
BackgroundAppel, K., Schwahn, C., Mahler, J., Schulz, A., Spitzer, C., Fenske, K., Stender, J., Barnow, S., John, U., Teumer, A., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.81 · Cited by 234 · cited 1×
“Furthermore, the FKBP5 modulated effects of childhood trauma in predicting major depression (Appel et al. 2011; Zimmermann et al. 2011).”
BackgroundGenetic predictors of response to antidepressants in the GENDEP project
Uher, R., Huezo-Diaz, P., Perroud, N., Smith, R., Rietschel, M., Mors, O., Hauser, J., Maier, W., Kozel, D., Henigsberg, N., et al. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.12 · Cited by 226 · cited 1×
“Variation in the HTR2A gene has been associated with antidepressant response or remission in a number of studies (Uher et al. 2009; Horstmann et al. 2010; Kishi et al. 2010; Lucae et al. 2010).”
BackgroundRitsner, M., Kurs, R., Gibel, A., Ratner, Y., & Endicott, J. (2005) · Quality of Life Research · doi:10.1007/s11136-005-2816-9 · Cited by 216 · cited 1×
“This is supported by a factor analysis on the QoL measure showing distinct factors ‘physical health’, ‘leisure time activities’, ‘social relationships’ and ‘subjective feelings’, the latter being more likely to overlap with variance explained by depressive symptoms (Ritsner et al. 2005).”
MethodAstrotactin provides a receptor system for CNS neuronal migration
Fishell, G., & Hatten, M. E. (1991) · Development · doi:10.1242/dev.113.3.755 · Cited by 212
Association of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort
Paddock, S., Laje, G., Charney, D., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Lipsky, R., Wisniewski, S. R., Manji, H., & McMahon, F. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111790 · Cited by 192 · cited 1×
“HTR2A influence on citalopram response was reproduced by Paddock et al. (2007) who used a larger STAR*D sample and examined another large number of candidate markers.”
MethodHorstmann, S., Lucae, S., Menke, A., Hennings, J. M., Ising, M., Roeske, D., Müller-Myhsok, B., Holsboer, F., & Binder, E. B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.180 · Cited by 183 · cited 1×
“Variation in the HTR2A gene has been associated with antidepressant response or remission in a number of studies (Uher et al. 2009; Horstmann et al. 2010; Kishi et al. 2010; Lucae et al. 2010).”
BackgroundPredictors of Mood Response to Acute Tryptophan Depletion A Reanalysis
Booij, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00361-5 · Cited by 182 · cited 1×
“We included age and sex as covariates since sociodemographic variables were associated with antidepressant response in the STAR*D (Drago & Serretti, 2011) and it has been found that sex mediates the effects of experimental manipulation of serotoninergic levels on mood (Booij et al. 2002).”
MethodPharmacogenetics of antidepressant response
Porcelli, S., Drago, A., Fabbri, C., Gibiino, S., Calati, R., & Serretti, A. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100059 · Cited by 177 · cited 1×
“On the other hand, there is a substantial research showing that candidate polymorphisms of target proteins may be involved in antidepressant drug action (Serretti et al. 2005; Kato & Serretti, 2010; Porcelli et al. 2011).”
BackgroundSelf-citationWilson, P. M., Fryer, R. H., Fang, Y., & Hatten, M. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0032-10.2010 · Cited by 169 · cited 2×
“The neuronal protein astrotactin (ASTN1) is a well-known receptor for glial-guided neuronal migration (Fishell & Hatten, 1991; Zheng et al. 1996), a fundamental process in the development of the laminar structure of cortical regions of the brain (Wilson et al. 2010).”
BackgroundHealth-Related Quality of Life in Depression: A Star*D Report
Daly, E. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Gaynes, B. N., Warden, D., Morris, D. W., Luther, J. F., Farabaugh, A., Cook, I., et al. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200107 · Cited by 168 · cited 3×
“Within the STAR*D trial, factors related to QoL have been previously examined and only age and depression severity were shown to have an important contribution (Daly et al. 2010), both factors being taken into account in the present analysis.”
MethodInfluentialAssociation of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort
Ballenger, J. C. (2009) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)79086-8 · Cited by 167
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Warden, D., McKinney, W., Downing, M., Berman, S. R., Farabaugh, A., Luther, J. F., Nierenberg, A. A., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0203 · Cited by 160
Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
Franchini, L., Serretti, A., Gasperini, M., & Smeraldi, E. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00004-1 · Cited by 156 · cited 1×
“There is substantial evidence that antidepressant response is to a certain extent heritable (O’Reilly et al. 1994; Franchini et al. 1998).”
BackgroundSelf-citationWGAViewer: Software for genomic annotation of whole genome association studies: Figure 1.
Ge, D., Zhang, K., Need, A. C., Martin, O., Fellay, J., Urban, T. J., Telenti, A., & Goldstein, D. B. (2008) · Genome Research · doi:10.1101/gr.071571.107 · Cited by 155 · cited 2×
“The WGAViewer program (http:// compute1.lsrc.duke.edu/softwares/WGAViewer/) was used for the inspection of the GWAS results (Ge et al. 2008).”
MethodKhoury, M. J., & Wacholder, S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn351 · Cited by 148
Role of Nuclear Factor κB in Ovarian Hormone-Mediated Stress Hypersensitivity in Female Mice
LaPlant, Q., Chakravarty, S., Vialou, V., Mukherjee, S., Koo, J. W., Kalahasti, G., Bradbury, K. R., Taylor, S. V., Maze, I., Kumar, A., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.024 · Cited by 136 · cited 1×
“NF-κB has been reported as a mediator of stress-impaired neurogenesis and depressive-like phenotypes (Koo et al. 2010), and mediator of stress response (LaPlant et al. 2009), in animal models.”
BackgroundSerretti, A., Benedetti, F., Zanardi, R., & Smeraldi, E. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.013 · Cited by 132 · cited 1×
“On the other hand, there is a substantial research showing that candidate polymorphisms of target proteins may be involved in antidepressant drug action (Serretti et al. 2005; Kato & Serretti, 2010; Porcelli et al. 2011).”
BackgroundSelf-citationDepression, IV: STAR*D Treatment Trial for Depression
Rush, A. J., Trivedi, M. H., & D, M. F. M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.237 · Cited by 126 · cited 1×
“The STAR*D trial has been previously described in detail elsewhere (Fava et al. 2003; Rush et al. 2003).”
MethodCornelis, M. C., Tchetgen, E. J. T., Liang, L., Qi, L., Chatterjee, N., Hu, F. B., & Kraft, P. L. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr368 · Cited by 120 · cited 2×
“Although some information may be lost due to this dichotomization, this saturated model may eliminate some mis-specification under the null hypothesis and decrease type I error (Cornelis et al. 2012).”
MethodInfluentialSample size requirements to detect gene-environment interactions in genome-wide association studies
Murcray, C. E., Lewinger, J. P., Conti, D. V., Thomas, D. C., & Gauderman, W. J. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20569 · Cited by 116 · cited 1×
“Our sample size has insufficient power to detect interaction effects (Murcray et al. 2011).”
BackgroundPharmacogenetic response to antidepressants in a multicase family with affective disorder
O’Reilly, R. L., Bogue, L., & Singh, S. M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90642-4 · Cited by 116 · cited 1×
“There is substantial evidence that antidepressant response is to a certain extent heritable (O’Reilly et al. 1994; Franchini et al. 1998).”
BackgroundPredictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder
Papakostas, G. I., & Fava, M. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/gipapakostas · Cited by 113 · cited 1×
“Whereas it is estimated that about 50% of patients with uncomplicated MDD will respond to any single antidepressant (Papakostas & Fava, 2008, 2009), other reports show lower response rates (Souery et al. 2007).”
BackgroundManic-depression genes and the new millennium: poised for discovery
Baron, M. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000998 · Cited by 107 · cited 2×
“2007) and in a linkage study of bipolar I and bipolar II (Baron, 2002).”
BackgroundGenetic Variants in FKBP5 Affecting Response to Antidepressant Drug Treatment
Kirchheiner, J., Lorch, R., Lebedeva, E., Seeringer, A., Roots, I., Sasse, J., & Brockmöller, J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.7.841 · Cited by 104 · cited 1×
“Furthermore, several significant SNPs were found within the FKBP5 gene, which has been previously associated with treatment outcome in depression in two independent studies (Binder et al. 2004; Kirchheiner et al. 2008).”
ResultGene–Environment Interaction in Major Depression and Antidepressant Treatment Response
Keers, R., & Uher, R. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-011-0251-x · Cited by 94 · cited 1×
“© Cambridge University Press 2013 doi:10.1017/S0033291713001554 ORIGINAL ARTICLE environments, and gene–environment (G×E) interactions implicated in aetiological pathways to depression may also play a role in predicting treatment response (Keers & Uher, 2012).”
BackgroundInfluentialGenes, Environment, and Individual Differences in Responding to Treatment for Depression
Uher, R. (2011) · Harvard Review of Psychiatry · doi:10.3109/10673229.2011.586551 · Cited by 92 · cited 2×
“Environmental factors, both early and late in life, also influence treatment response (Uher, 2011).”
BackgroundKeers, R., Uher, R., Huezo-Diaz, P., Smith, R. G., Jaffee, S. R., Rietschel, M., Henigsberg, N., Kozel, D., Mors, O. N., Maier, W., et al. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.14 · Cited by 90 · cited 1×
“…as on the serotonin-transporter-linked polymorphic region (5-HTTLPR) for example, may increase the risk for MDD (Uher & McGuffin, 2010) or may lead to a worse response to the SSRI treatment (Mandelli et al. 2009; Keers et al. 2011) under unfavourable psychosocial environmental conditions.”
BackgroundLinkage of Essential Hypertension to Chromosome 18q
Kristjánsson, K., Manolescu, A. R., Kristinsson, A., Hardarson, T., Knudsen, H., Ingason, S., Þorleifsson, G., Frigge, M. L., Kong, A., Gulcher, J. R., et al. (2002) · Hypertension · doi:10.1161/01.hyp.0000018580.24644.18 · Cited by 90 · cited 2×
“In addition, considering the role of the NEDD4L gene in processes involving sodium imbalances, polymorphisms in NEDD4L have been implicated extensively in hypertension (Kristjansson et al. 2002; Araki et al. 2008), as well as in treatment efficacy of β-blockers in hypertensive patients (Svensson-Färbom et al.”
BackgroundWong, M.-L., Dong, C., Andreev, V, Arcos-Burgos, M., & Licinio, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.13 · Cited by 89 · cited 5×
“Whereas it is estimated that about 50% of patients with uncomplicated MDD will respond to any single antidepressant (Papakostas & Fava, 2008, 2009), other reports show lower response rates (Souery et al. 2007).”
BackgroundInfluentialPharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results
Laje, G., Perlis, R. H., Rush, A. J., & McMahon, F. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1446 · Cited by 89 · cited 2×
“Our study also suffers from other limitations of the STAR*D trial, as already reported previously (Laje et al. 2009; Garriock et al. 2010).”
ResultCohen, R. M., Greenberg, J. M., & IsHak, W. W. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.286 · Cited by 86 · cited 2×
“…a recent study in the STAR*D sample showed that QoL was a factor that contributed significantly to the patients’ Individual Burden of Illness Index, and the variance explained by QoL was additional to that explained by depressive symptoms in a principal component analysis (Cohen et al. 2013).”
BackgroundCandidate and non-candidate genes in behavior genetics
Flint, J., & Munafò, M. R. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.07.005 · Cited by 85 · cited 1×
“There is increasing evidence emerging from GWASs that there are no genetic variants that contribute with a large effect (Flint & Munafo, 2013).”
BackgroundHTR2A gene variation is involved in antidepressant treatment response
Lucae, S., Ising, M., Horstmann, S., Baune, B. T., Arolt, V., Müller-Myhsok, B., Holsboer, F., & Domschke, K. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.08.006 · Cited by 85 · cited 1×
“Variation in the HTR2A gene has been associated with antidepressant response or remission in a number of studies (Uher et al. 2009; Horstmann et al. 2010; Kishi et al. 2010; Lucae et al. 2010).”
BackgroundThe current state of play on the molecular genetics of depression
Cohen-Woods, S., Craig, I. W., & McGuffin, P. (2013) · Psychological Medicine · doi:10.1017/s0033291712001286 · Cited by 82 · cited 1×
“Hence, apart from the large sample sizes that would provide sufficient power to observe small effects, designing multivariate models of prediction with the tools available in each study could assist in unravelling variants of risk (Cohen-Woods et al. 2013).”
BackgroundSvensson-Färbom, P., Wahlstrand, B., Almgren, P., Dahlberg, J., Fava, C., Kjeldsen, S., Hedner, T., & Melander, O. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283410390 · Cited by 77 · cited 2×
“…the role of the NEDD4L gene in processes involving sodium imbalances, polymorphisms in NEDD4L have been implicated extensively in hypertension (Kristjansson et al. 2002; Araki et al. 2008), as well as in treatment efficacy of β-blockers in hypertensive patients (Svensson-Färbom et al. 2011).”
BackgroundGenome-wide analysis of the maternal-to-zygotic transition in Drosophila primordial germ cells
Siddiqui, N. U., Li, X., Luo, H., Karaiskakis, A., Hou, H., Kislinger, T., Westwood, J. T., Morris, Q., & Lipshitz, H. D. (2012) · Genome biology · doi:10.1186/gb-2012-13-2-r11 · Cited by 71 · cited 2×
“org/) was used to produce networks of the top pathway list genes on the basis of their genetic interaction, physical interaction, co-expression or co-localization with the identified proteins, as used by other investigators (Siddiqui et al. 2012).”
MethodHTR2A is Associated with SSRI Response in Major Depressive Disorder in a Japanese Cohort
Kishi, T., Yoshimura, R., Kitajima, T., Okochi, T., Okumura, T., Tsunoka, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Naitoh, H., et al. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8105-y · Cited by 61 · cited 1×
“Variation in the HTR2A gene has been associated with antidepressant response or remission in a number of studies (Uher et al. 2009; Horstmann et al. 2010; Kishi et al. 2010; Lucae et al. 2010).”
BackgroundExpression, Transcription, and Possible Antagonistic Interaction of the Human Nedd4L Gene Variant
Araki, N., Umemura, M., Miyagi, Y., Yabana, M., Miki, Y., Tamura, K., Uchino, K., Aoki, R., Goshima, Y., Umemura, S., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.102061 · Cited by 55 · cited 2×
“In addition, considering the role of the NEDD4L gene in processes involving sodium imbalances, polymorphisms in NEDD4L have been implicated extensively in hypertension (Kristjansson et al. 2002; Araki et al. 2008), as well as in treatment efficacy of β-blockers in hypertensive patients (Svensson-Färbom et al.”
BackgroundPharmacogenetics of antidepressant response: An update
Drago, A., De Ronchi, D., & Serretti, A. (2008) · Human Genomics · doi:10.1186/1479-7364-3-3-257 · Cited by 51 · cited 1×
“To date, several variants within HTR2A have been proposed to affect antidepressant response, but failures to replicate findings also exist (Drago et al. 2009).”
BackgroundSelf-citationInteraction between SERTPR and stressful life events on response to antidepressant treatment
Mandelli, L., Marino, E., Pirovano, A., Calati, R., Zanardi, R., Colombo, C., & Serretti, A. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.08.005 · Cited by 50 · cited 2×
“…as on the serotonin-transporter-linked polymorphic region (5-HTTLPR) for example, may increase the risk for MDD (Uher & McGuffin, 2010) or may lead to a worse response to the SSRI treatment (Mandelli et al. 2009; Keers et al. 2011) under unfavourable psychosocial environmental conditions.”
BackgroundSelf-citationPyne, J. M., Bullock, D., Kaplan, R. M., Smith, T. L., Gillin, J. C., Golshan, S., Kelsoe, J. R., & Williams, D. K. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0408 · Cited by 30 · cited 2×
“For example, the patient’s quality of life (QoL) has been previously found to be an independent predictor of acute antidepressant treatment response (Pyne et al. 2001) and low QoL was associated with lower remission scores in the STAR*D trial (Trivedi et al.”
BackgroundGene × Environment Interaction Models in Psychiatric Genetics
Karg, K., & Sen, S. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_184 · Cited by 24 · cited 1×
“Ultimately, the assessment of important environmental adversities, such as childhood maltreatment, would be an important step in genomewide environment interactions (Karg & Sen, 2012), since such events play a significant role in the onset of depression and response to treatment (Uher, 2011).”
BackgroundGenome‐wide scan of bipolar II disorder
Nwulia, E. A., Miao, K., Zandi, P. P., MacKinnon, D. F., DePaulo, J. R., & McInnis, M. G. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00437.x · Cited by 19 · cited 2×
“Furthermore, the area where NEDD4L is located (namely, area 18q21–23) has been previously shown to contain significant loci in a GWAS of bipolar II disorder (Nwulia et al. 2007) and in a linkage study of bipolar I and bipolar II (Baron, 2002).”
The Pharmacogenetics of Depression: Enter the GWAS
Malhotra, A. K. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10020244 · Cited by 17 · cited 2×
“…of the phenotype, it has been suggested that alternative pharmacogenetic study designs should be considered, in particular those that take into account the manifold sociodemographic and environmental variables that make an impact on treatment response in the clinical setting (Malhotra, 2010).”
BackgroundDrago, A., & Serretti, A. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182189c64 · Cited by 16 · cited 2×
“Other sociodemographic and clinical characteristics, such as age, sex and symptom severity, known to influence response to treatment (Drago & Serretti, 2011), were also included in the model.”
BackgroundMethodSelf-citation
Cited by
Markers of Oxidative Stress and Neuroprogression in Depression Disorder
Vaváková, M., Ďuračková, Z., & Trebatická, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/898393 · Cited by 324
“SNPs in serotonergic genes can also alter antidepressants responses [84].”
BackgroundGenetic variants in major depressive disorder: From pathophysiology to therapy
Gonda, X., Petschner, P., Eszlári, N., Baksa, D., Édes, A. E., Antal, P., Juhász, G., & Bagdy, G. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.002 · Cited by 101
Fabbri, C., Kasper, S., Kautzky, A., Bartova, L., Dold, M., Zohar, J., Souery, D., Montgomery, S., Albani, D., Raimondi, I., et al. (2019) · British Journal of Psychiatry · doi:10.1192/bjp.2018.256 · Cited by 61
Self-citationLenze, E. J., Nicol, G. E., Barbour, D. L., Kannampallil, T., Wong, A. W. K., Piccirillo, J., Drysdale, A. T., Sylvester, C. M., Haddad, R., Miller, J. P., et al. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200042 · Cited by 43
Lawford‐Smith, H. (2015) · Journal of Social Ontology · doi:10.1515/jso-2015-0008 · Cited by 59
Metadata
- Authors
- Antypa, N., Drago, A., & Serretti, A.
- Affiliations
- University of Bologna (IT)
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- Corresponding author
- Serretti, A.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2013-07-01
- Volume
- 44
- Issue
- 4
- Pages
- 753-765
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2003632199
- Cited by
- 9
- References
- 68
- Citations by year
- 2025: 1 · 2021: 1 · 2020: 2 · 2018: 2 · 2015: 2 · 2014: 1
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- University of Toronto
- National Institute of Mental Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- antidepressant response, gene-environment interaction, quality of life, NEDD4L, serotonergic genes, depression, STAR*D trial, single nucleotide polymorphisms, candidate genes, treatment response prediction
- MeSH terms
- Nedd4 Ubiquitin Protein Ligases, Adult, Antidepressive Agents, Clinical Trials as Topic, Depression, Female, Humans, Male, Middle Aged, Pharmacogenetics, Predictive Value of Tests, Quality of Life, Polymorphism, Single Nucleotide, Ubiquitin-Protein Ligases, Genome-Wide Association Study, Endosomal Sorting Complexes Required for Transport, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.